Opportunities, challenges, and difficulties in NMR-based metabolomics applied to neovascular age-related macular degeneration (nAMD) patient follow-up
M. Schoumacher, V. Lambert, M. Campas, P. Blaise, B. Locht, M. Thys, E. Duchateau, E. Cavalier, J.-M. Rakic, A. Noël, P. de Tullio · 2025
Read Opportunities, challenges, and difficulties in NMR-based metabolomics applied to neovascular age-related macular degeneration (nAMD) patient follow-up by M. Schoumacher, V. Lambert, M. Campas, P. Blaise, B. Locht, M. Thys, E. Duchateau, E. Cavalier, J.-M. Rakic, A. Noël, P. de Tullio (2025) in the Tower of Babel, a free online library of public-domain works preserved in clean, searchable text. No sign-up. The full text is served as a plain-text file at a predictable URL, where text is present: https://antarctic-labs.com/tower-of-babel/pmc-11811626.txt.
Description
Schoumacher and co-authors report a study, published in 2024, on an eye disease that harms sight in older adults. The disease brings new blood vessels into the back of the eye. The team used a lab method that reads many small chemicals in blood. They tracked 29 patients for two years of care.
Blood tests, eye scans, and health checks gave 231 time points in all. The lab work counted more than 60 chemicals in each sample. Group-wide patterns proved hard to pin down, since care and disease varied a lot. Patient-by-patient checks worked better and found links for single people. The authors stress that study design matters for long trials.
Catalog record
| CREATOR | M. Schoumacher, V. Lambert, M. Campas, P. Blaise, B. Locht, M. Thys, E. Duchateau, E. Cavalier, J.-M. Rakic, A. Noël, P. de Tullio |
|---|---|
| YEAR | 2025 |
| COLLECTION | PAPERS |
| FORMAT | TXT |
| FILE SIZE | 56 KB |
| VERSION | 1.0 |
| LICENSE | CC BY 4.0 |
| RIGHTS | CC BY |
| SOURCE | Europe PMC |